C11,
I have considered the possibility that Covidity might get shelved, but after reading Crumb's views that it is as much about finding the positives and validating the science - platform (bigger picture) and of course Avidimab as Covidity itself hitting the back of the net with it's 1st shot!
As we know we have other players on the field that could easily knock us in a couple of rapid goals! There will be bumps in the road but surely overall momentum will mean we are not stopped in our tracks.
Scancell football shirt's anybody? Modi 1 SCIB 1 SCOV 2 Avidimab ...
Yes Thompi, nothing escapes your all seeing eye! And for once Angle seem to be ahead of us by making these updates although someone had found the Jeffries note as soon as it was published! Let’s see what it all means and how quick they confirm. I don’t think I have seen investors with as sharp an eye as here!
ATB
Thanks Dibs and Phantom,
Yes that's excellent information. I don't frequent the ADVFN board as I don't find it easy to navigate. That information filtered from there to Telegram twice recently. The potential purchase of 10 million shares by a new fund. Hmm, as Obi Wan would say, "that's not the news your looking for,' springs to mind. Commercial news on the other hand would be rocket fuel that we require. That is the only show in town as far as I can see. I hope the slides indicate something of a step in that direction, apart from just being very intriguing!
Anyway, my point was that we have excellent spotters between the three platforms and news on either front would be most welcome!
Was it spotted ADVFN first? Usually Telegram is days if not weeks ahead of certain RNS and these chat boards.
Yes we are talking about more distribution agreements in place as per latest slides. No credit to me, but the usual high quantity sleuths!
Bought in two years ago @ .36. We know what happened next! That was pandemic times. It seems to me that whilst COVID is less of a threat we have the same opportunity at these prices. So yes, I am buying at these levels.
Are we still thinking Artemis are selling down?
Although it was also posted on Telegram this morning.
https://twitter.com/parsortix/status/1590745828146413568?s=46&t=iWtyTH12XauefeCwG5am3w
Thanks Dege,
Not necessarily Parsortix of course as the detail is very ambiguous…
An explanation of CUP for those that do not know (I didn’t!)
https://www.cancerresearchuk.org/about-cancer/cancer-unknown-primary-cup
I am starting this thread to demonstrate examples of how Parsortix can be used in real life, research, clinical, monitoring applications. Please keep your answers to one application of Parsortix per post.
So I will start
Drug Development
Cancer cell analysis (Parsortix)
Appropriate Drug Administered
So from this example we can see that of the many drugs and therapies available, a clinician oncologist can have cancer cells tested (using Parsortix) so that the appropriate drug or combination therapy can be administered.
We could add to this post that Parsortix can also be used in drug development or monitoring but they would need to be articulated in a separate post.
Or we can just whinge about the share price!
I appreciate that this has most likely been covered before. Does anyone know the latest situation with the Redmile CLN’s?
Are we still due the £19.65 million. In other words we are likely to have access to more cash.
https://www.scancell.co.uk/Data/Sites/1/media/publications/rns/scancell-announcement-re-cln-extension-final-28.10.21.pdf
Think this was last updated at the last AGM 2021?
I appreciate we may not really know until the AGM this month.
Thanks
I agree with Ivy, Bermuda and AB.
If we have good data it will be published by the company.
This current rumour mill is more like UKOG or other such trashy share chat/rampfest.
Quite surprised that such high quality and usually level headed posters are jumping on the band wagon. Ok, the McMillan story is out now, if you believe it’s legit then accept it as a heads up and move on.
gs thanks for that,
Just made a similar point on Telegram that clinicians would be using Parsortix for analysis, identifying targets, using appropriate approved drugs. This particular market is health care providers. So quite a different market with likely very different dynamics too working with pharma on development drugs/immunotherapy.
I think its really good to analyse use of Parsortix. There are an element of people that have bought in expecting FDA approval and instant contracts and riches instantly. The reality is that commercialisation will be complex and nuanced IMO. These discussions might help us all understand what Angle are and have to do to get Parsortix where it needs to be!
Unfortunately I think a fair percentage of holders are purely interested in a return and they don't care about how it has to happen. That is likley why people have unrealistic timelines too.